Focus: JAMP Pharma is a generic pharmaceutical manufacturer headquartered in Quebec with 201-500 employees, focused on bringing affordable medications to market across multiple therapeutic areas including immunology.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow JAMP Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for JAMP Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from JAMP Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
No Relief from SC for Jamp India in Dispute with Jubilant Generics Over Drug Rights - Medical Dialogues
No Relief from SC for Jamp India in Dispute with Jubilant Generics Over Drug Rights Medical Dialogues
Supreme Court upholds interim relief in JAMP-Jubilant pharmaceutical product dossiers dispute - SCC Online
Supreme Court upholds interim relief in JAMP-Jubilant pharmaceutical product dossiers dispute SCC Online
JAMP Pharma Group Expands Oncology Portfolio with PrJAMP Enzalutamide - Newswire Canada
JAMP Pharma Group Expands Oncology Portfolio with PrJAMP Enzalutamide Newswire Canada
No open positions listed yet. Check their careers page directly.
Recent peer-reviewed publications with author affiliations at this company
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo